Bioprocessing Market Trends and Outsourcing Dynamics: 2016-2021

  • ID: 4035478
  • Report
  • Region: Global
  • 79 Pages
  • Industry Standard Research (ISR)
1 of 4

Manufacturing biologics is a much more involved and complicated process than the chemical synthesis required for small molecule drugs. As a result, some sponsors are unlikely to outsource the process because of its complexity. Others are more likely to outsource bioprocessing because they need access to scientific expertise not possessed inhouse.

The Bioprocessing Market Trends and Outsourcing Dynamics: 2016-2021 report affords readers the opportunity to gain insight into the bioprocessing market and where it’s heading. This report provides an overview of the current market dynamics for bioprocessing as well as an outlook on what our survey respondents predict the marketplace will look like in five years. The report also explores the types of biologics sponsor organizations currently have in development and on the market and the likelihood of outsourcing a bioprocessing project by the type of biologic.

How You Can Use This Report

Drug Developers

  • Gain insight into where the biologics industry is heading over the next five years with respect to protein expression systems utilized and types of biologics in development
  • Understand the CMO usage patterns of industry peers to identify whether additional outsourcing advatanges can be obtained for your organization
  • Learn the criteria used by peers to select bioprocessing contract manufacturers that help to scientifically and strategically evaluate service providers for bioprocessing projects

Contract Manufacturers

  • Pinpoint which CMO attributes have led to successful outsourcing relationships, those that have caused service providers to lose bids and what truly drives sponsor satisfaction, then internally assess your company on these metrics
  • Identify changes in demand for outsourced activities and services in order to prepare for future needs
  • Better position your company to win business by understanding the dynamics of different buyer groups (by sponsor company type and geography) and developing targeted marketing to speak directly to their unique needs
READ MORE
Note: Product cover images may vary from those shown
2 of 4

Copyright And Usage Guide 

Introduction

Methodology 

Respondent Demographics And Qualifications

  • Participant Geography
  • Participant Company Size

Study Findings 

  • Bioprocessing Market Dynamics
  • Motivations For Outsourcing Bioprocessing
  • Bioprocessing Project & Cmo Volume
  • Bioprocessing Project & Cmo Volume In 2021
  • Production Systems In Use
  • Production Systems In Use Continued
  • Types Of Biologics Manufactured
  • Types Of Biologics Manufactured By Company Size
  • Therapeutic Categories Of Biologics
  • Dollar Value Of Outsourced Bioprocessing
  • Projects
  • Service Provider Perceptions And Selection
  • Most Important Service Provider Attributes
  • Bioprocessing Contract Manufacturer Areas For Excellence—Unprompted
  • Top Reasons For Service Provider Preference
  • Top Service Provider Satisfaction Drivers
  • Top 5 Reasons Service Providers Lose Bids
  • Number Of Bioprocessing Preferred Providers
  • Trends, Predictions And Preferences
  • Biologics Market Growth Drivers-Unprompted
  • Geographic Preferences
  • Bioprocessing In China

Study Data 

  • Biologics In Development By Therapeutic Area
  • Marketed Biologics By Therapeutic Area
  • Marketed Biologics In 2021  By Therapeutic Area
  • Production Methods For Biologics In Development
  • Production Methods For Marketed Biologics
  • Production Methods Utilized In 2021
  • Biologics Pipeline By Production Platform
  • Marketed Products By Production Platform 35
  • Biologics Portfolio In 2021 By Production Platform
  • Biologics Portfolio By Type
  • Bioprocessing Project Volume
  • Motivations For Outsourcing Bioprocessing
  • Outsourced Bioprocessing Current And 5 Years Out
  • In-House Vs Outsourced Development Work
  • In-House Vs Outsourced Commercial Manufacturing
  • In-House Vs Outsourced Manufacturing In 2021
  • In-House Bioprocessing By Geographic Location
  • Outsourced Bioprocessing By Geographic Location
  • Bioprocessing In China
  • Likelihood Of Outsourcing Biologics In Development By Type
  • Likelihood Of Outsourcing Marketed Biologics By Type
  • Number Of Cmos Used To Meet Bioprocessing Needs
  • Use Of Preferred Providers
  • Number Of Preferred Providers
  • Preferred Provider Cmos
  • Mentioned Cmos
  • Difficulty In Using A Non-Preferred Provider
  • Frequency Of Modifying The Preferred Provider List
  • Frequency Of Reevaluating The Preferred Provider List
  • Annual Outsourced Bioprocessing Expenditure
  • Outsourced Expenditure By Production Platform
  • Bioprocessing Contract Manufacturer Areas For Excellence-Unprompted
  • Department Influence  On Cmo Selection
  • Cmo Selection Attributes
  • Service Provider Satisfaction Drivers
  • Reasons Service Providers Lose Bids
  • Service Provider Familiarity
  • Service Provider Consideration
  • Service Provider Use
  • Service Provider Preference
  • Top Reasons Expressed For Service Provider Preference-Unprompted
  • Verbatim Responses For Service Provider Preference
  • Biologics Market Growth Drivers-Unprompted

Demographics 

  • Company Type
  • Headquarters Location
  • Office Location
  • Job Title
  • Decision-Making Responsibility
  • Outsourcing Influence
  • Involvement In Outsourced Manufacturing
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll